Browse > Article

Relationship Between pSUV of $^{18}F$-FDG PET/CT and Pathological Diagnosis in Breast Cancer  

Kim, Mi-Young (Department of Diagnostic Radiology, Dankook University Hospital)
Publication Information
Journal of radiological science and technology / v.36, no.4, 2013 , pp. 305-311 More about this Journal
Abstract
The purpose of this study was to evaluate the Pathological Diagnosis associated with pSUV uptake of $^{18}F$-FDG PET/CT. We had enrolled 39 women that underwent $^{18}F$-FDG PET/CT before operative. We evaluated whether there was correlation between the pSUV of $^{18}F$-FDG PET/CT and prognostic factors. As a results, pSUV level increase according to tumor size but pSUV had no significant association with tumor size. pSUV of high histologic grade was higher than low histologic grade, and pSUV showed positive correlations with histologic grade. The ER and PR showed significant negative correlations with the pSUV of $^{18}F$-FDG PET/CT. Therefore, our results demonstrated that an correlation exists between pSUV and prognostic factors such as histologic grade, ER and PR.
Keywords
breast cancer; positron emission tomography uptake; pathological diagnosis;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Seo HI, Bae YT, Han KT, Kim SJ, Park DY: Clinicopathological Characteristics in Invasive Ductal Breast Cancer with Low FDG Uptake in $^{18}F$-FDG PET/CT. J Breast Cancer. 13(1), 83-89, 2010   DOI
2 Jadvar H, Alavi A, Gambhir SS: 18F-FDG Uptake in Lung, Breast, and Colon Cancers: Molecular Biology Correlates and Disease Characterization. J Nucl Med. 50, 1820-1827, 2009   DOI   ScienceOn
3 Avril N, Menzel M, Dose J, Schelling M, Weber W, Janicke F, et al: Glucose Metabolism of Breast Cancer Assessed by 18F-FDG PET: Histologic and Immunohistochemical Tissue Analysis. J Nucl Med. 42, 9-16, 2001
4 Buck AK, Schirrmeister H, Mattfeldt T, Reske SN: Biological Characterization of Breast Cancer by Means of PET. Eur J Nucl Med Mol Imaging. 31(1), 80-87, 2004   DOI
5 Kumar R, Chauhan A, Zhuang H, Chandra P, Schnall M, Alavi A: Clinicopathologic Factors Associated with False Negative FDG-PET in Primary Breast Cancer. Breast Cancer Res Treat. 98, 267-274, 2006   DOI   ScienceOn
6 Walter C, Scheidhauer K, Scharl A, Goering UJ, Theissen P, Kugel H, et al: Clinical and Diagnostic Value of Preoperative MR Mammography and FDG-PET in Suspicious Breast Lesions. Eur Radiol. 13, 1651-1656, 2003   DOI   ScienceOn
7 Rose C, Dose J, Avril N: Positron Emission Tomography for the Diagnosis of Breast Cancer. Nucl Med Commun. Vol.23, pp.613-618, 2002   DOI   ScienceOn
8 Avril N, Dose J, Janicke F, Bense S, Ziegler S, Lauvenvacher C, et al: Metabolic Characterization of Breast Tumors with Positron Emission Tomography Using F-18 Fluorodeoxyglucose. J Clin Oncol. 14, 1848-1857, 1996   DOI
9 Adler LP, Crowe JP, al-Kaisi NK, Sunshine JL: Evaluation of Breast Masses and Axillary Lymph Nodes with [F-18]2-deoxy-2-fluoro-D-glucose PET. Radiology. 187, 743-750, 1993   DOI
10 Hanahan D, Weinberg RA: The Hallmarks of Cancer. Cell. 100, 57-70, 2000   DOI   ScienceOn
11 Kostakoglu L, Goldsmith S: Fluorodeoxyglucose Positron Emission Tomography in the Staging and Follow-up of Lymphoma: Is It Time to Shift Gears?. Eur J Nucl Med. 27, 1564-1578, 2000   DOI   ScienceOn
12 Mac Manus M, Hicks R, Ball D, Kalff V, Matthews JP, Salminen E, et al: F-18 Fluorodeoxyglucose Positron Emission Tomography Staging in Radical Radiotherapy Candidates with Nonsmall Cell Lung Carcinoma: Powerful Correlation with Survival and High Impact on Treatment. Cancer. 92, 886-895, 2001   DOI   ScienceOn
13 Bae SY, Lee EH, Park JM, Kwak JJ: 18F-Fluorodeoxyglucose Positron Emission Tomography/CT Scan Findings for Ductal Carcinomas of Breast: Association of Standardized Uptake Value and Histological Findings. J Korean Soc Radiol. 66(2), 169-175, 2012   DOI
14 Hung G, Shiau Y, Tsai S, Chao T, Ho Y, Kao C: Value of 18F-Fluoro-2-deoxyglucose Positron Emission Tomography in the Evaluation of Recurrent Colorectal Cancer. Anticancer Res. 21, 1375-1378, 2001
15 Oshida M, Uno K, Suzuki M, Nagashima T, Hashimoto H, Yagata H, et al: Predicting the Prognoses of Breast Carcinoma Patients with Positron Emission Tomography Using 2-deoxy- 2-fluoro[$^{18}F$]-D-glucose. Cancer. 82, 2227- 2234, 1998   DOI   ScienceOn
16 Sorlie T: Molecular Portraits of Breast Cancer: Tumour Subtypes as Disease Entities. Eur J Cancer. 40, 2667-2675, 2004   DOI   ScienceOn
17 Jeong SH, Lee EH, Park JM, Lee HK, Yi BH, Choi N: Factors Affecting 18F-Fluorodeoxyglucose (FDG) Uptake in Breast Cancer. J Korean Soc Radiol. 63, 87-292, 2010
18 Groheux D, Moretti JL, Basillet G, Espie M, Giacchetti S, Hindie E: Effects of 18F-FDG PET/CT Imaging in Patients with Clinical Stage II and III Breast Cancer. Int J Radiat Cncol Biol Phys. 71, 2695-704, 2008
19 Gil-Rendo A, Martinez-Regueira F, Zomoza G, Garcia-Velloso MJ, Beorlegui C, Rodriguez- Spiteri N, et al: Association Between 18FFluorodeoxyglucose Uptake and Prognostic Parameters in Breast Cancer. Br J Surg. 96, 166-170, 2009   DOI   ScienceOn
20 Flope AL, Lyles RH, Sprouse JT, Conrad EU 3rd, Eary JF: [18-F]fluorodeoxyglucose Positron Emission Tomography as a Predictor of Pathologic Grade and Other Prognostic Variables in Bone and Soft Tissue Sarcoma. Clin Cancer Res. 6, 1279-1287, 2000
21 Basu S, Chen W, Tchou J, Mavi A, Cermik T, Czerniecki B, et al: Comparison of Triple-negative and Estrogen Receptor-positive/Progesterone Receptor-positive/HER2-negative Breast Carcinoma Using Quantitative Fluorine-18 Fluorodeoxyglucose/ Positron Emission Tomography Imaging Parameters: A Potentially Useful Method for Disease Characterization. Cancer. 112, 995-1000, 2008   DOI   ScienceOn
22 Mavi A, Cermilk TF, Urhan M, Puskulcu H, Basu S, Yu JQ, et al: The Effects of Estrogen, Progesterone, and C-erbB-2 Receptor States on 18F-FDG Uptake of Primary Breast Cancer Lesion. J Nucl Med. 48, 1266-1272, 2007   DOI   ScienceOn